MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
GTHX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

G1 Therapeutics (GTHX) Ownership - Who owns G1 Therapeutics?

G1 Therapeutics Inc is a commercial-stage biopharmaceutical company... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
700 Park Offices Drive
Phone
+1 919 213-9835
Employees
100
Web
https://www.g1therapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
377.22M
P/E Ratio
N/A
Total Cash
60.73M
Projected Growth
N/A
Total Debt
47.96M
Revenue
58.2M
Risk (Beta)
1.29
Dividend Yield
N/A
Total Cash/Share
1.15
Total Debt/Equity
N/A
Revenue/Share
1.12 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for GTHX
A.I. Advisor
published General Information

General Information

a developer of drugs for cancer treatment

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Major
Address
700 Park Offices Drive
Phone
+1 919 213-9835
Employees
100
Web
https://www.g1therapeutics.com